[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100267065":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":12,"locations":22,"responsibleParty":40,"collaborators":7,"id":42,"slug":7,"hasResults":43,"nctId":44,"briefTitle":45,"officialTitle":46,"acronym":47,"eligibilityCriteria":48,"healthyVolunteers":43,"sex":49,"minAge":50,"maxAge":51,"enrollmentInfo":52,"targetDuration":7,"studyType":55,"phases":7,"briefSummary":56,"conditions":57,"keywords":59,"overallStatus":25,"whyStopped":7,"lastUpdateSubmitDate":61,"lastUpdatePostDateStruct":62,"startDateStruct":65,"completionDateStruct":67,"leadSponsor":69,"locationsCount":70},{"fullName":5,"class":6},"Imperial College London","OTHER",null,[9],{"name":10,"affiliation":5,"role":11},"Jadwiga Wedzicha","PRINCIPAL_INVESTIGATOR",[13,18],{"name":14,"role":15,"phone":16,"phoneExt":7,"email":17},"Jadwiga A Wedzicha, MD","CONTACT","2075947947","j.wedzicha@imperial.ac.uk",{"name":19,"role":15,"phone":20,"phoneExt":7,"email":21},"Gavin C Donaldson, PhD","207 4947859","gavin.donaldson@imperial.ac.uk",[23],{"facility":24,"status":25,"city":26,"state":7,"zip":27,"country":28,"cosmosGeoPoint":29,"geoPoint":34,"contacts":35},"National Heart and Lung Institute, Imperial College","RECRUITING","London","SW3 6LR","United Kingdom",{"type":30,"coordinates":31},"Point",[32,33],-0.12574,51.50853,{"lat":33,"lon":32},[36,38],{"name":19,"role":15,"phone":37,"phoneExt":7,"email":21},"44 (0) 207 594 7859",{"name":14,"role":15,"phone":39,"phoneExt":7,"email":17},"44 (0) 207 594 7947",{"type":41,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100267065",false,"NCT02755974","The London COPD Exacerbation Cohort","Relationship Between Patient Phenotypes and Exacerbations in Chronic Obstructive Pulmonary Disease.","EXCEL_Cohort","Inclusion Criteria:\n\n* Forced Expiratory Volume in 1 sec (FEV1)\u002FForced Vital Capacity (FVC) ratio of \\\u003C0.70\n* Able and willing to give informed and written consent\n\nExclusion Criteria:\n\n* Patients with a history of asthma, bronchiectasis, carcinoma of the bronchus, or other significant respiratory disease were excluded.\n* Patients on Immunosuppressive medications or with active cancer\n* Long term steroid therapy\n* Age \\\u003C40 years at recruitment","ALL","40 Years","100 Years",{"count":53,"type":54},300,"ESTIMATED","OBSERVATIONAL","The London COPD exacerbation (EXCEL) cohort builds on an established cohort started in 1995 and designed to study COPD exacerbations and their impact on health-status and disease progression.",[58],"Pulmonary Disease, Chronic Obstructive",[60],"Chronic Obstructive Pulmonary Disease","2022-06-16",{"date":63,"type":64},"2022-06-21","ACTUAL",{"date":66,"type":64},"2009-01",{"date":68,"type":54},"2026-12-31",{"name":5,"class":6},1]